Copyright
©2006 Baishideng Publishing Group Co.
World J Gastroenterol. Jan 14, 2006; 12(2): 322-326
Published online Jan 14, 2006. doi: 10.3748/wjg.v12.i2.322
Published online Jan 14, 2006. doi: 10.3748/wjg.v12.i2.322
Figure 2 Significant decrease of activated and quiescent HSCs by 48-wk losartan treatment in a patient with NASH (double immunostaining with anti-p75 and α-SMA antibodies, × 200).
- Citation: Yokohama S, Tokusashi Y, Nakamura K, Tamaki Y, Okamoto S, Okada M, Aso K, Hasegawa T, Aoshima M, Miyokawa N, Haneda M, Yoneda M. Inhibitory effect of angiotensin II receptor antagonist on hepatic stellate cell activation in non-alcoholic steatohepatitis. World J Gastroenterol 2006; 12(2): 322-326
- URL: https://www.wjgnet.com/1007-9327/full/v12/i2/322.htm
- DOI: https://dx.doi.org/10.3748/wjg.v12.i2.322